Beta

Chemed corporationCHE.US Overview

US StockHealthcare
(No presentation for CHE)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

CHE AI Insights

CHE Overall Performance

CHE AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CHE Recent Performance

-0.38%

Chemed corporation

-1.10%

Avg of Sector

-0.49%

S&P500

CHE PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check CHE's Trend

CHE Key Information

CHE Valuation Metrics

CHE Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Price of CHE

CHE FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CHE Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
19.37
PE Ratio (TTM)
22.96
Forward PE
16.21
PS Ratio (TTM)
2.23
PB Ratio
5.25
Price-to-FCF
14.86
METRIC
VALUE
vs. INDUSTRY
Gross Margin
31.71%
Net Margin
10.23%
Revenue Growth (YoY)
2.07%
Profit Growth (YoY)
-7.04%
3-Year Revenue Growth
5.49%
3-Year Profit Growth
1.63%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
19.37
PE Ratio (TTM)
22.96
Forward PE
16.21
PS Ratio (TTM)
2.23
PB Ratio
5.25
Price-to-FCF
14.86
Gross Margin
31.71%
Net Margin
10.23%
Revenue Growth (YoY)
2.07%
Profit Growth (YoY)
-7.04%
3-Year Revenue Growth
5.49%
3-Year Profit Growth
1.63%
  • When is CHE's latest earnings report released?

    The most recent financial report for Chemed corporation (CHE) covers the period of 2026Q1 and was published on 2026/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CHE's short-term business performance and financial health. For the latest updates on CHE's earnings releases, visit this page regularly.

  • Where does CHE fall in the P/E River chart?

    According to historical valuation range analysis, Chemed corporation (CHE)'s current price-to-earnings (P/E) ratio is 19.48, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of CHE?

    According to the latest financial report, Chemed corporation (CHE) reported an Operating Profit of 84.58M with an Operating Margin of 12.86% this period, representing a decline of 10.74% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CHE's revenue growth?

    In the latest financial report, Chemed corporation (CHE) announced revenue of 657.51M, with a Year-Over-Year growth rate of 1.63%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CHE have?

    As of the end of the reporting period, Chemed corporation (CHE) had total debt of 236.93M, with a debt ratio of 0.15. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CHE have?

    At the end of the period, Chemed corporation (CHE) held Total Cash and Cash Equivalents of 16.86M, accounting for 0.01 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CHE go with three margins increasing?

    In the latest report, Chemed corporation (CHE) achieved the “three margins increasing” benchmark, with a gross margin of 30.25%%, operating margin of 12.86%%, and net margin of 10.08%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CHE's profit trajectory and future growth potential.

  • Is CHE's EPS continuing to grow?

    According to the past four quarterly reports, Chemed corporation (CHE)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 4.85. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CHE?

    Chemed corporation (CHE)'s Free Cash Flow (FCF) for the period is 71.1M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 263.22% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of CHE?

    The latest valuation data shows Chemed corporation (CHE) has a Price-To-Earnings (PE) ratio of 19.48 and a Price/Earnings-To-Growth (PEG) ratio of -1.69. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.